We are thrilled to announce that PharmEng Technology has joined the Efor Group, marking a transformative chapter in our journey as a leading provider of life sciences consulting services. This strategic partnership strengthens our capacity to deliver world-class solutions while expanding our global reach and expertise.

A Unified Global Vision for Life Sciences

As part of this collaboration, PharmEng Technology becomes an integral part of a dynamic group of 2,800 employees operating across 12 countries. Together, we are positioned to address the intricate challenges of the pharmaceutical, biotechnology, and medical device industries with enhanced resources and an even broader perspective.

Combining Strengths to Deliver Comprehensive Solutions

For over 25 years, PharmEng Technology has been synonymous with excellence in validation, quality assurance, regulatory affairs, and engineering. Joining forces with Efor allows us to enhance these strengths, offering integrated solutions that span the entire lifecycle of healthcare products—from initial research and development to market launch, regulatory compliance, and post-market vigilance.

This partnership empowers us to better support the rapidly evolving needs of the life sciences industry, delivering tailored solutions that reflect the complexities and opportunities of today’s global market.

A Shared Commitment to Innovation and Excellence

“This partnership represents an exciting opportunity to unite two organizations with shared values and a common vision,” said Alan Kwong, Founder and President of PharmEng Technology. “By combining our strengths, we’re able to offer unparalleled support to life sciences companies across three continents.”

Mathieu Roger, Founder and President of Efor, echoed this enthusiasm: “This union marks a pivotal moment in our mission to transform the life sciences sector. Together, we will drive innovation, exceed expectations, and deliver excellence for our clients worldwide.”

About Efor Group

Founded in 2013, the Efor Group has become one of the European leaders in life sciences consulting. With a team of over 2,500 employees across four countries (France, Belgium, Switzerland, and the United States) and generating a revenue of 240 million euros in 2024, the group offers a comprehensive range of services, from R&D to vigilance, to support its clients throughout the entire lifecycle of healthcare products.

Shaping the Future of Life Sciences Consulting

This milestone underscores our unwavering commitment to being a trusted partner for the life sciences industry. With a strengthened ability to anticipate trends, drive innovation, and deliver impactful solutions, we are more equipped than ever to support our clients in achieving their goals.

As we embark on this new chapter, we remain dedicated to providing the high-quality services and personalized expertise that have defined PharmEng Technology for decades. Together with Efor, we look forward to shaping the future of the life sciences sector and exceeding expectations at every step.